Latest period
$750.74M
YoY change
-39.8%
5Y CAGR
-0.1%
Peak year (2024)
$1.30B
Latest annual
$781.08M
Cash on Hand history chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: $781.08M
Cash on Hand growth chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: -39.8%
Cash on Hand history table for Teladoc Health (TDOC) from 2013 to 2025
| 2025 | $781.08M | -39.8% | −$517.24M | ||
| 2024 | $1.30B | +15.5% | +$174.65M | ||
| 2023 | $1.12B | +22.4% | +$205.49M | ||
| 2022 | $918.18M | +2.5% | +$22.16M | ||
| 2021 | $896.02M | +13.9% | +$109.45M | ||
| 2020 | $786.57M | +52.1% | +$269.50M | ||
| 2019 | $517.06M | +8.1% | +$38.53M | ||
| 2018 | $478.53M | +291.3% | +$356.23M | ||
| 2017 | $122.31M | +85.9% | +$56.50M | ||
| 2016 | $65.81M | -52.1% | −$71.54M | ||
| 2015 | $137.35M | +195.8% | +$90.91M | ||
| 2014 | $46.44M | +1345.7% | +$43.22M | ||
| 2013 | $3.21M | — | — |
- 2025$781.08M-39.8%
- 2024$1.30B+15.5%
- 2023$1.12B+22.4%
- 2022$918.18M+2.5%
- 2021$896.02M+13.9%
- 2020$786.57M+52.1%
- 2019$517.06M+8.1%
- 2018$478.53M+291.3%
- 2017$122.31M+85.9%
- 2016$65.81M-52.1%
- 2015$137.35M+195.8%
- 2014$46.44M+1345.7%
- 2013$3.21M—
Cash on Hand values are taken from Teladoc Health's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at Teladoc Health (TDOC)
According to Teladoc Health's latest reported financial statements, the company's latest reported cash and short-term investments is $750.74M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Teladoc Health (TDOC) most recent annual cash and short-term investments stands at $781.08M (2025) – plunged 39.8% year-over-year.
Across 2020–2025 (5 years), Teladoc Health cash and short-term investments produced a CAGR of -0.1% – with a net decline across the window.
Teladoc Health cash and short-term investments peaked at $1.30B in 2024; the latest annual figure is $781.08M in 2025 (39.8% below peak).
The highest annual cash and short-term investments of $1.30B was reported in 2024. The lowest in the available history was $3.21M in 2013.
Teladoc Health Cash on Hand by Year
Teladoc Health Cash on Hand 2025: $781.08M
Teladoc Health posted cash and short-term investments of $781.08M in 2025, plunged 39.8% below 2024.
Teladoc Health Cash on Hand 2024: $1.30B
In 2024, Teladoc Health reported cash and short-term investments of $1.30B, grew 15.5% from 2023. This figure represents the highest annual value in the available history.
Teladoc Health Cash on Hand 2023: $1.12B
Teladoc Health cash and short-term investments in 2023 was $1.12B, grew 22.4% from 2022.
Teladoc Health Cash on Hand 2022: $918.18M
2022's cash and short-term investments for Teladoc Health came in at $918.18M, edged up 2.5% from 2021.
Teladoc Health Cash on Hand 2021: $896.02M
Teladoc Health cash and short-term investments in 2021 was $896.02M.
See more financial history for Teladoc Health (TDOC).
Sector peers by Cash on Hand
Healthcare peers of Teladoc Health (TDOC), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
Teladoc Health (TDOC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation